Delphia (Usa) Inc. Johnson & Johnson Transaction History

Delphia (Usa) Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $53,713 - $57,806	-348 Reduced 14.93%	1,983 $328,000
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $28,246 - $33,708	187 Added 8.72%	2,331 $361,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $83,143 - $93,311	-519 Reduced 19.49%	2,144 $378,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $547,554 - $609,290	-3,394 Reduced 56.03%	2,663 $435,000
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $312,328 - $345,420	1,857 Added 44.21%	6,057 $1.08 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $137,581 - $156,243	870 Added 26.13%	4,200 $744,000
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $519,246 - $576,123	3,330 New	3,330 $570,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.